BrightSpring Health Financials - Benzinga

BrightSpring Health Services Inc

BTSGNASDAQ

Trade with Public

Trade with Public

$60.20

1.041.76%

Ult. Agg.: Sep 2, 3:34 PM

Panoramica Notizie Previsioni utili Eventi Obiettivi di prezzoDati finanziariSentiment Azionariato Confronta Opzioni Rapporto azionario

BrightSpring Health Financials

BrightSpring Health (BTSG) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
BrightSpring Health Q2 Adj. EPS $0.45 Beats $0.40 Estimate, Sales $3.873B Beat $3.658B Estimate

BrightSpring Health (NASDAQ:BTSG) reported quarterly earnings of $0.45 per share which beat the analyst consensus estimate of $0.40 by 12.5 percent. This is a 104.55 percent increase over earnings of $0.22 per share

Benzinga Newsdesk

PRO
BrightSpring Health Raises FY2026 Sales Guidance from $14.725B-$15.225B to $15.100B-$15.425B vs $15.064B Est

BrightSpring Health (NASDAQ:BTSG) raises FY2026 sales outlook from $14.725 billion-$15.225 billion to $15.100 billion-$15.425 billion vs $15.064 billion estimate.

Benzinga Newsdesk

BrightSpring Health Analysts Increase Their Forecasts Following Q1 Results

BrightSpring Health Services (BTSG) reported strong Q1 results with increased full-year guidance. Analysts have raised price targets for stock.

Avi Kapoor

BrightSpring Extends Rally With Solid Q1, Upgraded Fiscal 2026 Forecast

BrightSpring shares rise after Q1 earnings beat, revenue growth and raised FY26 guidance; analysts cite momentum but note valuation premium.

Vandana Singh

Earnings Scheduled For May 1, 2026

Benzinga Insights

PRO
BrightSpring Health Raises FY2026 Sales Guidance from $14.450B-$15.000B to $14.725B-$15.225B vs $14.847B Est

Full Year 2026 Financial GuidanceFor the full year 2026, BrightSpring is increasing Revenue and Adjusted EBITDA guidance, which excludes the Community Living business and the effects of any future closed acquisitions.

Benzinga Newsdesk

© 2026 Benzinga | All Rights Reserved